What the company does
Asterasys makes aesthetic medical devices that tighten and rejuvenate skin without surgery, supplying clinics and hospitals in South Korea and internationally.
Its flagship product, Liftera, uses high-intensity focused ultrasound, a technology that delivers targeted energy beneath the skin, and is designed to reduce treatment discomfort while improving results. Listed on KOSDAQ, South Korea's tech-focused small-cap exchange, the company earns the bulk of its revenue from the Liftera product line while expanding its portfolio with newly approved non-invasive radiofrequency devices.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2024US$20.9M
- FY2025US$27.5M
Operating profit
- FY2024US$4.8M
- FY2025US$7.5M
Net income
- FY2024US$3.9M
- FY2025US$6.7M
Key ratios (FY2025)
Why it matters · Context, not a recommendation
New products have received approval from South Korea's MFDS, the national medical-device regulator, and are pursuing separate US FDA clearance to access international markets.
Price charts coming soon
Interactive price history isn't here yet. Would you use it?